Clicky

Iterum Therapeutics plc(ITRM)

Description: Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.


Keywords: Pharmaceutical Stage Pharmaceutical

Home Page: www.iterumtx.com

ITRM Technical Analysis

Fitzwilliam Court
Dublin, 2
Ireland
Phone: 353 1 669 4820


Officers

Name Title
Mr. Corey N. Fishman Pres, CEO & Director
Ms. Judith M. Matthews Chief Financial Officer
Dr. Michael W. Dunne M.D. Strategic Advisor & Director
Dr. Sailaja Puttagunta M.D. Chief Medical Officer
Mr. Tom Loughman Ph.D. Sr. VP of Technical Operations
Ms. Louise Barrett Sr. VP of Legal Affairs & Sec.
Dr. Steven I. Aronin M.D. Sr. VP & Head of Clinical Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 7.5
Price-to-Book MRQ: 0.4454
Price-to-Sales TTM: 1349.785
IPO Date: 2018-05-25
Fiscal Year End: December
Full Time Employees: 13
Back to stocks